Suchergebnisse - "Caffo, Orazio"

PubPharm (290)

1

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy : the ARON-2 study

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

2

Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study

enthalten in: Cancer immunology immunotherapy | 2024

von Massari, F. | Santoni, M. | Takeshita, H. | +94

3

Immune-Related Adverse Events Due to Cancer Immunotherapy : Immune Mechanisms and Clinical Manifestations

enthalten in: Cancers | 2024

von Casagrande, S. | Sopetto, G. | Bertalot, G. | +6

4

Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma : A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study

enthalten in: Clinical genitourinary cancer | 2024

von Mollica, V. | Massari, F. | Maruzzo, M. | +22

5

Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer

enthalten in: The EMBO journal | 2024

von Alaimo, A. | Genovesi, S. | Annesi, N. | +33

6

Significance of PD-L1 in Metastatic Urothelial Carcinoma Treated With Immune Checkpoint Inhibitors : A Systematic Review and Meta-Analysis

enthalten in: JAMA network open | 2024

von Maiorano, B. | Di Maio, M. | Cerbone, L. | +104

7

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation

enthalten in: Cancer discovery | 2024

von Franceschini, G. | Quaini, O. | Mizuno, K. | +25

8

Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care

enthalten in: Prostate cancer and prostatic diseases | 2024

von Conteduca, V. | Di Tullio, P. | Allamprese, R. | +21

9

A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study)

enthalten in: Therapeutic advances in medical oncology | 2024

von Sepe, P. | Procopio, G. | Pircher, C. | +16

10

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors : a meta-analysis

enthalten in: Frontiers in cardiovascular medicine | 2024

von Inno, A. | Veccia, A. | Madonia, G. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]